Pulmonary and hepatic metastases of low-grade urothelial cell carcinoma; A case report.

Michael Smith, Tirth Patel, Mark Vangorder, James Siegert

Abstract readCase Reports

In one paragraph

Article in Urology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael SmithFranciscan Health Olympia Fields, 20201 South, Crawford Ave, Olympia Fields, IL, 60461, USA.

Tirth PatelMidwestern University, 555 31st St, Downers Grove, IL, 60515, USA.

Mark VangorderFranciscan Health Olympia Fields, 20201 South, Crawford Ave, Olympia Fields, IL, 60461, USA.

James SiegertFranciscan Health Olympia Fields, 20201 South, Crawford Ave, Olympia Fields, IL, 60461, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is a commonly encountered malignancy of the genitourinary tract. Bladder cancer is categorized as high or low grade depending on histological analysis. Low grade urothelial cell carcinoma has an indolent clinical course as compared to high grade, with low rates of progression of disease. We present a case where a patient was identified to have low grade bladder cancer and subsequently found to have low grade bladder cancer metastases to the lung and liver. Although uncommon, low grade urothelial cell carcinoma has the potential for progression and metastasis, highlighting the importance of regular follow-up and surveillance.

Indexed as

Case reportCT, Computerized tomographyLow gradeMetastasesTransurethral resection of bladder tumorTURBT, Transurethral resection of bladder tumorUCC, Urothelial cell carcinomaUrothelial cell cancerWHO, World Health Organization

Identifiers

PMID34527518

DOI10.1016/j.eucr.2021.101836

PMCPMC8430390

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.